Bal Pharma Standalone June 2024 Net Sales at Rs 73.13 crore, up 4.22% Y-o-Y
August 17, 2024 / 10:28 IST
Reported Standalone quarterly numbers for Bal Pharma are:Net Sales at Rs 73.13 crore in June 2024 up 4.22% from Rs. 70.17 crore in June 2023.
Quarterly Net Profit at Rs. 1.75 crore in June 2024 up 46.27% from Rs. 1.20 crore in June 2023.
EBITDA stands at Rs. 7.89 crore in June 2024 up 8.23% from Rs. 7.29 crore in June 2023.
Bal Pharma EPS has increased to Rs. 1.11 in June 2024 from Rs. 0.76 in June 2023.
| Bal Pharma shares closed at 112.14 on August 14, 2024 (NSE) and has given -6.94% returns over the last 6 months and 23.57% over the last 12 months. |
| Bal Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 73.13 | 94.58 | 70.17 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 73.13 | 94.58 | 70.17 | | EXPENDITURE | | Consumption of Raw Materials | 36.31 | 51.89 | 41.57 | | Purchase of Traded Goods | 2.98 | 4.76 | 1.42 | | Increase/Decrease in Stocks | -0.34 | -2.89 | -4.20 | | Power & Fuel | -- | -- | -- | | Employees Cost | 13.84 | 14.56 | 13.20 | | Depreciation | 2.08 | 1.76 | 2.12 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 13.27 | 15.94 | 11.34 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.00 | 8.55 | 4.72 | | Other Income | 0.81 | 2.23 | 0.45 | | P/L Before Int., Excpt. Items & Tax | 5.81 | 10.79 | 5.17 | | Interest | 3.71 | 4.12 | 3.64 | | P/L Before Exceptional Items & Tax | 2.11 | 6.67 | 1.53 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 2.11 | 6.67 | 1.53 | | Tax | 0.36 | 0.45 | 0.34 | | P/L After Tax from Ordinary Activities | 1.75 | 6.22 | 1.20 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 1.75 | 6.22 | 1.20 | | Equity Share Capital | 15.80 | 15.80 | 15.69 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.11 | 4.16 | 0.76 | | Diluted EPS | 1.11 | 4.18 | 0.76 | | EPS After Extra Ordinary | | Basic EPS | 1.11 | 4.16 | 0.76 | | Diluted EPS | 1.11 | 4.18 | 0.76 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
